A 10-year retrospective study of the clinical presentation, pathology, treatment and outcomes of ameloblastoma and ameloblastic carcinoma in a teaching hospital in Lagos, Nigeria
The National Medical Journal of India · 2026
DOI: 10.25259/nmji_309_2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift The National Medical Journal of India, 2026. Verfasst von Uchenna Patrick Egbunah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Lagos University Teaching Hospital, Lagos, Nigeria. Hauptthemen laut MEDLINE: Ameloblastoma, Mandibular Neoplasms, Odontogenic Tumors. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Ameloblastoma is a common benign, odontogenic tumour with high prevalence in Africans, particularly Nigerians. We describe the epidemiology, clinicopathology, pattern of management and incidence of recurrence of ameloblastoma and ameloblastic carcinoma, in Lagos, Nigeria.
Methods
This retrospective study included ameloblastoma cases surgically managed at the Lagos University Teaching Hospital from January 2012 to December 2021. Primary outcome was recurrence; secondary outcomes were length of hospital (LOH) stay and postoperative complications.
Results
We included 63 patients with a mean (SD) age of 34.2 (14.8) years, peak incidence (31.7%) in the 3rd decade of life, and male-to-female ratio of 1.03. The most common location, radiological feature and histological type were posterior mandible (77.8%), multilocular radiolucency (90.5%) and follicular ameloblastoma (50.8%), respectively. For surgical intervention, majority of patients had nasotracheal intubation (67.3%) and mandibulectomy (88.9%), and the most common surgical approach was extraoral (67.3%). The mean (SD) LOH stay was 9.4 (2.4) days, and the transoral approach was associated with shortened LOH. The mean follow-up was 2.7 years, and recurrence was recorded in 2 patients who had conventional ameloblastoma, and one who had ameloblastic carcinoma at 3 years and 3 months postoperatively, respectively. No significant association was noted for recurrence-free survival based on tumour size, tumour diagnosis, histological type and surgical approach (p>0.05).
Conclusion
Although the epidemiology, clinicopathology and treatment of ameloblastoma reported were similar to older reports, this study provides more recent information on the persistent public health burden of ameloblastoma, which can be used for comparisons with ameloblastoma in other populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Lagos University Teaching Hospital, Lagos, Nigeria.
- Department of Clinical Evidence, AO ITC Clinical Evidence, AO Innovation Translation Center, Clinical Sciences, Dubendorf, Switzerland.
- Department of Clinical Operations, AO Innovation Translation Center, Zizers, Switzerland.
- Department of Surgical Sciences, Oral and Maxillofacial Surgery, Uppsala University, Uppsala, Sweden.
- Department of Oral and Maxillofacial Surgery, Faculty of Dental Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
Zitieren
APA
Egbunah, U. P., Zhu, Y. T., Hauri, D., Ratz, T., Thor, A. L., & Arotiba, G. T. (2026). A 10-year retrospective study of the clinical presentation, pathology, treatment and outcomes of ameloblastoma and ameloblastic carcinoma in a teaching hospital in Lagos, Nigeria. The National Medical Journal of India. https://doi.org/10.25259/nmji_309_2024
Vancouver
Egbunah UP, Zhu YT, Hauri D, Ratz T, Thor AL, Arotiba GT. A 10-year retrospective study of the clinical presentation, pathology, treatment and outcomes of ameloblastoma and ameloblastic carcinoma in a teaching hospital in Lagos, Nigeria. The National Medical Journal of India. 2026. doi:10.25259/nmji_309_2024
BibTeX
@article{Egbunah2026,
author = {Egbunah, Uchenna Patrick and Zhu, Yaner Tracy and Hauri, Dimitri and Ratz, Tiara and Thor, Andreas Li and Arotiba, Godwin Toyin},
title = {A 10-year retrospective study of the clinical presentation, pathology, treatment and outcomes of ameloblastoma and ameloblastic carcinoma in a teaching hospital in Lagos, Nigeria},
journal = {The National Medical Journal of India},
year = {2026},
doi = {10.25259/nmji_309_2024}
}
EUVIMED